Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 2,515 | 19,024 | 18,123 | 1,293 | 19,286 |
| Gross Profit | 2,515 | 19,024 | 18,123 | 1,293 | 19,286 |
| Operating Expenses | 31,908 | 31,450 | 68,572 | 105,197 | 130,923 |
| Operating Income | -29,393 | -12,426 | -50,449 | -103,904 | -111,637 |
| Interest Expense | 1,949 | 2,286 | 2,356 | 3,127 | 3,501 |
| Other Income | 4,556 | -289 | 66 | 2 | 744 |
| Pre-tax Income | -26,786 | -15,001 | -52,739 | -107,029 | -114,394 |
| Income Tax | 101 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -26,887 | -15,001 | -52,739 | -107,029 | -114,394 |
| Net Income | $-26,887 | $-15,001 | $-52,739 | $-107,029 | $-114,394 |
| EPS Basic Total Ops | -3.90 | -2.70 | -10.10 | -21.00 | -26.40 |
| EPS Basic Continuous Ops | -3.88 | -2.69 | -10.09 | -21.02 | -26.37 |
| EPS Diluted Total Ops | -3.90 | -2.70 | -10.10 | -21.00 | -26.40 |
| EPS Diluted Continuous Ops | -3.88 | -2.69 | -10.09 | -21.02 | -26.37 |
| EPS Diluted Before Non-Recurring Items | -4.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-29,349 | $-2,825 | $-44,009 | $-99,088 | $-106,681 |